PLA2G7 and metabolic syndrome: These risk factors include metabolic syndrome, diabetes, an increased proportion of small, dense LDL particles, lipoprotein-associated phospholipase A2 (Lp-PLA2), apoB/apoA ratio, lipoprotein(a), and proprotein convertase subtilisin/kexin 9 (PCSK9) [28,53].